By Professor Caroline Ford

Journal articles

Ford CE; Henry C; Llamosas E; Djordjevic A; Hacker N, 2016, 'Wnt signalling in gynaecological cancers: A future target for personalised medicine?', Gynecologic Oncology, 140, pp. 345 - 351, http://dx.doi.org/10.1016/j.ygyno.2015.09.085

Henry CE; Knipprath-Meszaros AM; Llamosas E; Schotzau A; Obermann E; Fink D; Hacker N; Ward RL; Heinzelmann-Schwarz V; Ford CE, 2015, 'ROR2 IS A NOVEL TARGET OF THE WNT SIGNALING PATHWAY INVOLVED IN METASTASIS AND CHEMOTHERAPY RESISTANCE', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 25, pp. 476 - 476, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000377145701094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE, 2015, 'Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling', Journal of Cancer Research and Clinical Oncology, 141, pp. 243 - 254, http://dx.doi.org/10.1007/s00432-014-1824-y

Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C, 2015, 'Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion', Oncotarget, 6, pp. 40310 - 40326, http://dx.doi.org/10.18632/oncotarget.5643

Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V, 2014, 'The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer', Gynecologic Oncology, 134, pp. 338 - 345, http://dx.doi.org/10.1016/j.ygyno.2014.06.004

Ford CE; Ma SSQ; Quadir A; Ward RL, 2013, 'The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis', International Journal of Cancer, 133, pp. 779 - 787, http://dx.doi.org/10.1002/ijc.27984

Ford CE; Jary E; Ma SSQ; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL, 2013, 'The WNT gatekeeper SFRP4 modulates EMT, cell migration and downstream WNT signalling in serous ovarian cancer cells', PLoS ONE, 8, pp. e54362, http://dx.doi.org/10.1371/journal.pone.0054362

Loh YN; Hedditch E; Baker L; Jary E; Ward RL; Ford CE, 2013, 'The Wnt signalling pathway is upregulated in acquired Tamoxifen resistant breast cancer.', BMC Cancer, 13, pp. 174, http://dx.doi.org/10.1186/1471-2407-13-174

Ford CE; Jary E; Ma S; Nixdorf S; Heinzelmann-Schwarz V; Ward RL, 2012, 'SFRP4 modulates EMT, cell migration and downstream Wnt signalling in epithelial ovarian cancer.', CANCER RESEARCH, 72, http://dx.doi.org/10.1158/1538-7445.AM2012-333

Jacob F; Ukegjini K; Nixdorf S; Ford CE; Olivier J; Caduff R; Scurry J; Guertler R; Hornung D; Mueller R; Fink D; Hacker NF; Heinzelmann-Schwarz VA, 2012, 'Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients', PLoS One, 7, pp. Art no. e31885, http://dx.doi.org/10.1371/journal.pone.0031885

Ford CE; Ekström EJ; Howlin J; Andersson T, 2011, 'The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer (Cell Cycle (2009), 8, (1838-1842))', Cell Cycle, 10, pp. 1167, http://dx.doi.org/10.4161/cc.10.7.15488

Johal H; Ford CE; Glenn W; Heads J; Lawson JS; Rawlinson WD, 2011, 'Mouse mammary tumor like virus sequences in breast milk from healthy lactating women', Breast Cancer Research and Treatment, 129, pp. 149 - 155, http://dx.doi.org/10.1007/s10549-011-1421-6

Ford CE; Ekström EJ; Andersson T, 2010, 'Erratum: Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells (Proceedings of the National Academy of Sciences of the United Stated of America (2010) 106 (3919-3924) DOI: 10.1073/pnas.0809516106))', Proceedings of the National Academy of Sciences of the United States of America, 107, pp. 22360, http://dx.doi.org/10.1073/pnas.1017549108

Ford CE; Ekström EJ; Howlin J; Andersson T, 2009, 'The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer', Cell Cycle, 8, pp. 1838 - 1842, http://dx.doi.org/10.4161/cc.8.12.8863

Ford CE; Ekström EJ; Andersson T, 2009, 'Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells', Proceedings of the National Academy of Sciences of the United States of America, 106, pp. 3919 - 3924, http://dx.doi.org/10.1073/pnas.0809516106

Ford CE; Lau S; Zhu CQ; Andersson T; Tsao M; Vogel W, 2007, 'Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.', British Journal of Cancer, 96, pp. 808 - 814, http://dx.doi.org/10.1038/sj.bjc.6603614

Lawson JS; Tran D; Carpenter E; Ford C; Rawlinson WD; Whitaker NJ; Delprado W, 2006, 'Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer', Journal of Clinical Pathology, 59, pp. 1287 - 1292

Vogel W; Abdulhussein R; Ford CE, 2006, 'Sensing extracellular matrix: An update on discoidin domain receptor function.', Cellular Signalling, 18, pp. 1108 - 1116

Pogo B; Menard S; Holland JF; Faedo M; Ford CE; Rawlinson WD, 2005, 'Contribution by Faedo et al. (Clin Cancer Res 2004;10:4417-4419) [1]', Clinical Cancer Research, 11, pp. 406

Faedo M; Ford CE; Rawlinson WD, 2005, 'Contribution by Faedo et al. Response', CLINICAL CANCER RESEARCH, 11, pp. 406 - 406, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000226110300054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ford CE; Faedo M; Delprado W; Rawlinson WD, 2004, 'Correspondence re: C. Ford, et al. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women.', Clinical Cancer Research, 10, pp. 802 - 802

Lawson JS; Tran D; Ford CE; Rawlinson WD, 2004, 'Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer', Breast Cancer Research and Treatment, 87, pp. 13 - 17

Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD, 2004, 'Mouse mammary tumor like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer', Clinical Cancer Research, 10, pp. 4417 - 4419

Ford CE; Faedo M; Rawlinson WD, 2004, 'Mouse mammary tumor virus-like RNA transcripts and DNA are found inaffected cells of human breast cancer', Clinical Cancer Research, 10, pp. 7284 - 7289

Ford CE; Faedo M; Lawson JS; Rawlinson WD; Crouch R, 2004, 'Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women.', Cancer research, 64, pp. 4755 - 4759

Ford CE; Tran D; Deng Y; Ta VT; Rawlinson WD; Lawson JS, 2003, 'Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women', Clinical Cancer Research, 9, pp. 1118 - 1120

Back to profile page